Key Insights

Highlights

Success Rate

68% trial completion

Published Results

14 trials with published results (48%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

27.6%

8 terminated out of 29 trials

Success Rate

68.0%

-18.5% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

82%

14 of 17 completed with results

Key Signals

14 with results68% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (14)
Early P 1 (2)
P 1 (4)
P 2 (5)
P 4 (1)

Trial Status

Completed17
Terminated8
Unknown2
Recruiting2

Trial Success Rate

68.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT03079921Early Phase 1Completed

Adrenergic System in Islet Transplantation

NCT03970720Phase 2RecruitingPrimary

Restoration of Hypoglycemia Awareness With Metoclopramide

NCT04614168Not ApplicableCompleted

Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes

NCT04825366Not ApplicableCompleted

Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training

NCT03608163Phase 4Terminated

Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)

NCT02213003Phase 1Completed

Allogeneic Islet Cells Transplanted Onto the Omentum

NCT05317455Early Phase 1Recruiting

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

NCT03215914Not ApplicableCompleted

Hybrid Closed Loop Insulin Delivery System in Hypoglycemia

NCT03748433Not ApplicableTerminated

Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia

NCT04854135Not ApplicableTerminated

Continuous Glucose Monitoring Initiation at Hospital Discharge

NCT04452396Not ApplicableTerminated

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

NCT04304963Completed

Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS

NCT01474889Not ApplicableCompletedPrimary

Glucose Counterregulation in Long Standing Type 1 Diabetes

NCT02700048Phase 1TerminatedPrimary

Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia

NCT05620927Unknown

Hypoglycemia Awareness Study in Diabetes Type 1

NCT03490942Phase 2TerminatedPrimary

Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses

NCT02747680Not ApplicableCompleted

Cerebral Responses to Insulin Induced Hypoglycemia

NCT03538015Phase 2TerminatedPrimary

Carvedilol in Treating Hypoglycemia Unawareness

NCT03665870Not ApplicableCompleted

Prevention Through Intervention: Telehealth Solution to Deter 911 Calls Due to Hypoglycemia

NCT03556033Phase 2Completed

Effect of Dapagliflozin on IAH in T1DM

Scroll to load more

Research Network

Activity Timeline